Klotho Neurosciences, Inc. KLTO 深 沪
已收盘 03-11 16:00:00 美东时间
0.5242
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.5242
- 总市值 5666.01万
- 52周最高 3.9099
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.1135
- 委 比 0.00%
- 总股本 1.08亿
- 历史最高 13.10
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.00
- 每 手 1
- 风险率 0.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Klotho Neurosciences To Change Name To Greenland Mines, Ticker To Change To 'GRML' Effective From March 12
The rebranding and ticker change reflect the Company's strategic expansion into natural resources following the recently announced acquisition of Greenland Mines Corp. and control of the Skaergaard Project in
03-09 20:40
Klotho Neurosciences Expands Into Mining With Greenland Mines Deal
Klotho Neurosciences acquires Greenland Mines, gaining access to Skaergaard Project with an estimated $68 billion palladium and gold resource.
03-04 21:02
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Curanex Pharmaceuticals (NASDAQ:CURX) shares moved upwards by 57.7% to...
02-27 01:05
Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It
Coinbase Global Inc. CEO Brian Armstrong said Monday, January 5, that his longevity startup, NewLimit, is working on extending human lifespan by treating age-related diseases.
01-06 15:24
Klotho Neurosciences Files Prospectus For Offer And Resale By Selling Stockholders Of Up To 34.9M Shares Of Common Stock
KLOTHO NEUROSCIENCES, INC. Up to a Maximum of 35,000,000 Shares of Common Stock This prospectus relates to the offering and resale from time to time by the selling stockholders identified herein of up to
2025-12-06 06:33
Klotho Neurosciences Q3 EPS $(0.05) Up From $(0.18) YoY
Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increase over losses of $(0.18) per share from the same period last year.
2025-11-14 06:42
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team ...
2025-10-16 20:00
Klotho Neurosciences Announces Expiration of Letter of Intent
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed t...
2025-10-08 06:20
Klotho Neurosciences to acquire select assets from Turn Biotechnologies
Klotho Neurosciences (NASDAQ:KLTO) said on Tuesday that it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies. Under the LOI, Klotho would acquire Turn's ERA ("Epi...
2025-09-30 21:25
Klotho Neurosciences Faces Nasdaq Delisting Notice
The latest update is out from Klotho Neurosciences ( ($KLTO) ). On September 19...
2025-09-26 04:54
